Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Pei Li Teh & An-hwa Lee
  • September 8, 2020
  • Webinars

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Our experts consider the impact the pandemic has and will continue to have on marketing in global healthcare and look at the continued shift towards digital communications as a means to engage physicians and patients.  

read more »

Has the reality of virtual conferences lived up to their promise?

Has the reality of virtual conferences lived up to their promise?

Using findings from a recent poll conducted among Oncologists, Harrison Gaiger explores what they really thought of ASCO 2020 and discusses the the changing nature of medical conferences.

In March, much of the world went in to lockdown and the prospect of medical conferences running as normal became unimaginable. Seeing no alternative, many organisers who would have spent months meticulously planning their upcoming events made the difficult decision to cancel. The more optimistic among them opted to postpone until 2021, while some deferred indefinitely. However, among the flurry of cancellations and postponements, some professional bodies and event organisers saw an opportunity to go a different route. As the old saying goes, “Necessity is the mother of invention”.

read more »

  • Posted by Julie Denny
  • August 24, 2020
  • News

Consumer health specialist joins Research Partnership

Consumer health specialist joins Research Partnership

Jennifer Stewart has joined the US offices in Philadelphia as a Director. Jennifer is a seasoned market research professional with extensive experience in both custom research and marketing consultation. She has 20+ years’ experience on the supplier side with a primary focus on Consumer Healthcare and CPG. Though adept at qualitative research, Jennifer has particular expertise and interest in quantitative research and analysis.

read more »

Dermatology experience and expertise

Dermatology experience and expertise

Did you know we have conducted more than 180 qualitative and quantitative research projects in dermatology?

Our latest infographic, designed by our in-house creative services team, The Studio,  outlines our considerable experience and expertise in delivering global pharmaceutical market research insights in dermatology.

read more »

  • Posted by Dan Coffin
  • August 21, 2020
  • Articles

Why pharma must trust the science of behaviour

Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin explained why the application of behavioural science will be key to better health far beyond COVID-19.

Last month, as the world began to tiptoe its way out of lockdown, a Sky News anchor declared that COVID-19 had ‘exposed behavioural science’ as ‘a load of nonsense’. The rationale? That behavioural scientists’ influence over the UK government’s COVID response caused a delay in lockdown that cost thousands of lives. The scientists’ logic was that if restrictions were imposed too early, ‘behavioural fatigue’ would soon set in and people might sleepwalk back into dangerous habits before the pandemic had peaked. Increases in road traffic that began three weeks into lockdown suggest the thinking had some merit. But the subsequent death toll – and hindsight – tell a different story. Today, months into a crisis where we’re consistently told to ‘trust the science’, the science of behaviour is under the microscope. However, to debate behavioural theory solely through the lens of the coronavirus – using death as the guiding metric – is to minimise its value. Human behaviour is complex, but understanding what drives it – and designing communications that encourage people to do things differently – is key to facilitating positive change. Dismissing behavioural science as blather – a bitter irony in Sky News’ case, given the broadcaster’s mastery of conscious bias…

read more »